When Sample Preparation Makes THC and CBD Look the Same by GC-MS

An instrument can perform exactly as programmed and still produce an identification problem. The problem may begin before the sample reaches the instrument.

That is the lesson of a 2012 Journal of Analytical Toxicology paper by R. Andrews and S. Paterson. Under the derivatization conditions they studied, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) produced identical retention times and mass spectra. The finding was not a general indictment of gas chromatography-mass spectrometry. It was a warning about a particular sample-preparation reaction: derivatization with trifluoroacetic anhydride and 1,1,1,3,3,3-hexafluoroisopropanol, commonly abbreviated TFAA-HFIP.

The practical point is simple. A laboratory cannot interpret a peak as though the derivatization step were chemically invisible.

What derivatization is supposed to do

Some compounds are difficult to analyze directly by gas chromatography. A laboratory may derivatize them before injection to improve volatility, thermal behavior, chromatographic performance, or detector response. Derivatization deliberately changes the chemical form of the analyte so the instrument can measure it more effectively.

That step can be useful, but it also becomes part of the analytical method. The reagent, reaction temperature, reaction time, solvent, and cleanup conditions can affect what reaches the column. A reliable interpretation therefore requires more than a recognizable mass spectrum. It requires proof that the preparation chemistry preserves the distinction the method claims to measure.

For background, see Derivatization in GC-MS and Laboratory Sample Preparation.

What Andrews and Paterson observed

Andrews and Paterson compared the behavior of THC and CBD after derivatization. With trimethylsilyl derivatives, the compounds remained analytically distinguishable under the reported conditions. With TFAA-HFIP, however, THC and CBD produced the same retention times and mass spectra.

The authors explained the result through reaction chemistry. CBD has an open-ring structure that can cyclize under acidic conditions. TFAA creates an acidic environment. Under the tested conditions, that environment permitted conversion of CBD into THC-related products. The same preparation also produced multiple peaks associated with THC isomerization.

The danger is not merely that two naturally similar compounds happen to overlap. The preparation step can change the material being measured. If CBD is transformed during derivatization, the instrument may accurately detect the product of the laboratory reaction while the analyst mistakenly attributes that result entirely to THC that existed in the original sample.

Why matching retention time and mass spectrum may not be enough

Forensic identification often relies on multiple analytical characteristics. Retention time supplies chromatographic information. A mass spectrum supplies fragment-ion information. Agreement with a reference material can be powerful evidence when the method is selective and the sample and reference are treated comparably.

But apparently independent characteristics can cease to be independent when one chemical reaction makes two starting compounds converge on the same analytical product. If THC and CBD acquire the same retention behavior and mass spectrum after TFAA-HFIP derivatization, those two matches do not prove which starting compound was present before the reaction.

A second published study identified a related problem in a different analytical setting. Broecker and Pragst examined THC and CBD during positive electrospray ionization for LC-MS/MS. Although the compounds have different structures, they produced identical collision-induced-dissociation spectra under the positive-ionization conditions studied. The authors interpreted the behavior as acid-catalyzed in-source equilibration and concluded that fragment spectra or multiple-reaction-monitoring ion ratios alone were not sufficient to distinguish THC from CBD. Retention time or other experimental evidence was required.

The two papers describe different mechanisms: one concerns derivatization before GC-MS, while the other concerns behavior during positive electrospray ionization. Together they show why apparently matching mass-spectral features cannot be treated as automatically independent proof of the original compound.

This is a selectivity problem. Selectivity asks whether the method can distinguish the target analyte from other substances reasonably expected in the sample. It is not answered merely by showing that the instrument detects a clean peak. See Analytical Selectivity in Toxicology and Chromatographic Resolution.

Questions for technical review

When a cannabinoid result depends on derivatized GC-MS analysis, a technical review should identify the exact preparation chemistry. Useful records include the standard operating procedure, reagent lot and preparation records, reaction conditions, calibrator and control chromatograms, validation studies, interference experiments, and raw case data.

The review should then separate three propositions:

• The instrument detected a reproducible analytical signal.
• The method identified a particular derivative or reaction product.
• The original specimen contained the claimed starting compound before laboratory preparation.

Those propositions may be related, but they are not automatically identical. The third requires evidence that the preparation did not create the ambiguity.

The bottom line

The instrument sees what reaches it. It does not independently reconstruct what existed before extraction, derivatization, and ionization.

Andrews and Paterson demonstrated a concrete example in which TFAA-HFIP sample preparation caused THC and CBD to produce identical retention times and mass spectra under the tested conditions. Broecker and Pragst demonstrated that positive electrospray ionization could yield identical THC and CBD fragment spectra under their conditions. Those findings turn preparation and ionization from background details into central identification issues.

Before a THC identification is accepted, the complete method should demonstrate that CBD cannot become an indistinguishable analytical product under the laboratory's actual conditions. A clean chromatogram does not cure a chemical ambiguity created before or during detection.

Sources

• Andrews R, Paterson S. Production of identical retention times and mass spectra for delta-9-THC and cannabidiol following derivatization with trifluoracetic anhydride with 1,1,1,3,3,3-hexafluoroisopropanol. Journal of Analytical Toxicology. 2012;36(1):61-65. doi:10.1093/jat/bkr017.
• Broecker S, Pragst F. Isomerization of cannabidiol and delta-9-tetrahydrocannabinol during positive electrospray ionization: In-source hydrogen/deuterium exchange experiments by flow injection hybrid quadrupole-time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry. 2012;26(12):1407-1414. Wiley journal record. doi:10.1002/rcm.6244.

This article paraphrases the published papers. The source PDFs, publisher layouts, figures, and tables are not reproduced.